masoprocol has been researched along with Colorectal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, W; Liao, F; Liu, M; Lv, L | 1 |
| Greger, H; Hausott, B; Marian, B | 1 |
| Eling, T; Geller, M; Kamitani, H | 1 |
3 other study(ies) available for masoprocol and Colorectal Neoplasms
| Article | Year |
|---|---|
Hepatoma-derived growth factor promotes the resistance to anti-tumor effects of nordihydroguaiaretic acid in colorectal cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspase 8; Caspase Inhibitors; Cell Line, Tumor; Colorectal Neoplasms; Cytochromes c; Drug Resistance, Neoplasm; Humans; Intercellular Signaling Peptides and Proteins; Male; Masoprocol; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Transplantation, Heterologous | 2010 |
Naturally occurring lignans efficiently induce apoptosis in colorectal tumor cells.
Topics: Adenoma; Animals; Apoptosis; Carcinoma; Cell Cycle; Cell Line; Cell Line, Tumor; Colorectal Neoplasms; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Intestinal Mucosa; Lignans; Lipoxygenase Inhibitors; Masoprocol; Phytotherapy; Plant Extracts; Plant Structures; Plants, Medicinal; Rats | 2003 |
Expression of 15-lipoxygenase by human colorectal carcinoma Caco-2 cells during apoptosis and cell differentiation.
Topics: Apoptosis; Arachidonate 15-Lipoxygenase; Butyrates; Butyric Acid; Caco-2 Cells; Cell Differentiation; Colorectal Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Indomethacin; Isoenzymes; Lipoxygenase Inhibitors; Masoprocol; Membrane Proteins; Prostaglandin-Endoperoxide Synthases | 1998 |